Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel

Br J Dermatol. 2000 Apr;142(4):808-11. doi: 10.1046/j.1365-2133.2000.03432.x.

Abstract

Docetaxel (Taxotere), a semisynthetic taxoid, acts as an antimicrotubule agent and is considered to have great potential in the treatment of non-small cell lung cancer, advanced breast cancer, ovarian cancer and some other tumours. Well-recognized side-effects include dose-limiting neutropenia, fluid retention, myalgia, neuropathy, hypersensitivity reaction, alopecia, mucositis, nail changes and cutaneous reactions such as acral erythema. We describe a unique docetaxel-induced cutaneous reaction presenting as fixed erythematous plaque(s) unrelated to extravasation or previous skin injury; histopathological studies were performed in three of the four cases.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Drug Eruptions / etiology*
  • Erythema / chemically induced*
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects*
  • Paresthesia / chemically induced*

Substances

  • Antineoplastic Agents, Phytogenic
  • Paclitaxel